The main reason for choosing BH Cellular Medicine is the DOCTORS. Drs. Bertolotto and Heneidi are academic researchers who have spent many years looking at stem cells under a microscope, performing research and learning how these types of cells work in the human body. They are true experts in the field. Dr. Bertolotto and Dr. Heneidi have developed processes from their years of research and have submitted those to the FDA. The doctors are committed to following the guidance of the FDA to ensure safety. Dr. Bertolotto has treated over 2000 patients in her clinic in Uruguay (her home country) and her processes have been reviewed by the Uruguayan Ministry of Public Health. Over more than 11 years, Dr. Bertolotto has real results which demonstrate safety and efficacy.
301 N. Canon Drive, Suite 305
Beverly Hills, California 90210
© 2026 | BH Cellular Medicine | All Rights Reserved. All content and images are property of Cristina Bertolotto, MD and cannot be saved or duplicated without expressed written consent.
DISCLAIMER: The information provided on this website is for general educational purposes only and is not medical advice. Any references to cellular or regenerative approaches describe areas of ongoing scientific and clinical research. Except where specifically identified as an FDA‑approved product, the cellular procedures discussed on this website have not been evaluated or approved by the US Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or condition. FDA has stated that stem cell products and products derived from adipose tissue of the type described here have not been approved to treat orthopedic, neurologic, cardiopulmonary, autoimmune, or other chronic conditions.(fda.gov)
Any cellular procedure carries potential risks, and benefits are uncertain. Decisions about care should be made in consultation with a licensed healthcare professional who can review all conventional and investigational options. BH Cellular Medicine endeavors to operate in compliance with applicable US laws and regulations governing human cells, tissues, and cellular and tissue‑based products (HCT/Ps), including requirements under section 361 of the Public Health Service Act and 21 CFR Part 1271, where applicable.(fda.gov)
PHOTO CITATION: Image source: Nature Reviews Endocrinology, March 2010 issue. File name: “NATURE-ENDOCRINOLGY-BH-CELLULAR-1920px.png”.
